Stifel Nicolaus Boosts GE HealthCare Technologies (NASDAQ:GEHC) Price Target to $102.00

GE HealthCare Technologies (NASDAQ:GEHC) had its target price lifted by Stifel Nicolaus from $100.00 to $102.00 in a research report sent to investors on Monday morning, Benzinga reports. Stifel Nicolaus currently has a buy rating on the stock.

GEHC has been the subject of several other reports. Redburn Atlantic raised shares of GE HealthCare Technologies to a strong-buy rating in a research note on Thursday, August 1st. JPMorgan Chase & Co. assumed coverage on shares of GE HealthCare Technologies in a research note on Monday, September 9th. They issued a neutral rating and a $90.00 price target for the company. BTIG Research upgraded shares of GE HealthCare Technologies from a neutral rating to a buy rating and set a $100.00 price objective for the company in a report on Wednesday, September 18th. Finally, UBS Group cut shares of GE HealthCare Technologies from a neutral rating to a sell rating and reduced their price objective for the company from $84.00 to $74.00 in a report on Thursday, September 26th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating, seven have given a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of Moderate Buy and an average target price of $94.23.

GE HealthCare Technologies Stock Performance

Shares of GE HealthCare Technologies stock opened at $91.04 on Monday. GE HealthCare Technologies has a fifty-two week low of $62.35 and a fifty-two week high of $94.55. The company has a debt-to-equity ratio of 1.05, a current ratio of 1.06 and a quick ratio of 0.82. The firm has a market capitalization of $41.56 billion, a P/E ratio of 26.62, a P/E/G ratio of 3.40 and a beta of 1.17. The company’s 50 day moving average price is $85.83 and its two-hundred day moving average price is $83.33.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings results on Wednesday, July 31st. The company reported $1.00 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.98 by $0.02. The firm had revenue of $4.84 billion during the quarter, compared to the consensus estimate of $4.88 billion. GE HealthCare Technologies had a net margin of 8.10% and a return on equity of 25.26%. The company’s revenue for the quarter was up .5% on a year-over-year basis. During the same quarter last year, the firm earned $0.92 earnings per share. On average, equities analysts forecast that GE HealthCare Technologies will post 4.26 earnings per share for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be issued a dividend of $0.03 per share. This represents a $0.12 dividend on an annualized basis and a dividend yield of 0.13%. The ex-dividend date of this dividend is Friday, October 18th. GE HealthCare Technologies’s payout ratio is presently 3.51%.

Insider Transactions at GE HealthCare Technologies

In other GE HealthCare Technologies news, CEO Thomas J. Westrick sold 2,750 shares of the business’s stock in a transaction dated Wednesday, August 7th. The stock was sold at an average price of $80.78, for a total transaction of $222,145.00. Following the completion of the sale, the chief executive officer now owns 17,509 shares of the company’s stock, valued at $1,414,377.02. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 0.27% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Wynn Capital LLC boosted its stake in GE HealthCare Technologies by 4.1% in the 1st quarter. Wynn Capital LLC now owns 3,125 shares of the company’s stock worth $284,000 after purchasing an additional 122 shares during the period. EverSource Wealth Advisors LLC boosted its stake in GE HealthCare Technologies by 8.7% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,590 shares of the company’s stock worth $135,000 after purchasing an additional 127 shares during the period. Quarry LP increased its stake in GE HealthCare Technologies by 28.3% in the 2nd quarter. Quarry LP now owns 594 shares of the company’s stock worth $46,000 after acquiring an additional 131 shares during the last quarter. Quent Capital LLC raised its holdings in shares of GE HealthCare Technologies by 21.3% during the 1st quarter. Quent Capital LLC now owns 780 shares of the company’s stock worth $71,000 after acquiring an additional 137 shares in the last quarter. Finally, Tempus Wealth Planning LLC boosted its position in shares of GE HealthCare Technologies by 0.5% during the 2nd quarter. Tempus Wealth Planning LLC now owns 30,892 shares of the company’s stock valued at $2,407,000 after acquiring an additional 141 shares during the last quarter. 82.06% of the stock is currently owned by institutional investors.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.